bluebird bio (BLUE) Debt to Equity Ratio

Current and historical debt to equity ratio values for bluebird bio (BLUE) over the last 10 years.

Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $5.870B $0.006B
Bluebird Bio, Inc. is a biotechnology company. It focuses on the development, manufacture and marketing of therapies for severe genetic disorders such as childhood cerebral adrenoleukodystrophy, neurodegenerative disorders and beta-thalassemia. The company operates in the U.S. and Europe. Bluebird Bio, Inc. is headquartered in Cambridge, Massachusetts.